About Richard Gaster
Richard Gaster is a director at Entact Bio.
Form D filings also name Richard Gaster as a director at Aeovian Pharmaceuticals, Alumis and Attralus.
Richard Gaster reports to the SEC as a director of 2 public companies: Ventyx Biosciences (VTYX) and Elevation Oncology (ELEV).
Richard Gaster first appears on SEC filings in 2019.
Experience
This experience comes from Richard Gaster's profile and from SEC filings. For roles taken from filings, the years are when the filings name Richard Gaster in the role, so the role may have started earlier or lasted longer.
OB
Oak Hill Bio Current
Board Member
2026 – Present
PF
Pediatric Brain Tumor Foundation Current
Board Member
2026 – Present
MY
Myoventive Current
Board Member
2025 – Present
Entact Bio, Inc. Current
Director
2021 – Present · Watertown, MA
Develops medicines that enhance protein function for people with diseases.
NV
NorthSea Therapeutics B.V. Current
Board Member
2020 – Present
AT
Arrakis Therapeutics Current
Board Member
2019 – Present
VP
venBio Partners Current
Managing Partner
2017 – Present
YB
Yarrow Bioscience
Board Observer
2025 – 2026
35
35Pharma
Board Member
2022 – 2026
VI
Ventyx Biosciences, Inc.
Director
2021 – 2023 · Public company (VTYX)
AI
ACELYRIN, INC.
Board Member
2021 – 2023
EI
Elevation Oncology, Inc.
Director
2021 · Public company (ELEV)
PH
Pharvaris
Board Member
2019 – 2021
HB
Harmony Biosciences
Board Observer
2017 – 2020
AT
Akero Therapeutics
Board Observer
2018 – 2019
PT
Pliant Therapeutics
Head of Translational Medicine
2016 – 2017
TV
Third Rock Ventures
Senior Associate
2015 – 2016
WE
wearBiō
Founder & Inventor
2013 – 2016
Key Colleagues at Startups
The people Richard Gaster works with at each company, as listed on that company's latest Form D.
Entact Bio, Inc. · Form D, Jun 3, 2026
AS
Andrew Sinclair
Director

Anna French
Director

Pini Orbach
Director

Victoria Richon
CEO, Board Member
OS
Owen Smith
Board Member
Aeovian Pharmaceuticals, Inc. · Form D, Dec 22, 2025
JK
John Kincaid
Executive officer
YB
Youssef Bennani
Director
TK
Themasap Khan
Director
NR
Nils Regge
Director
DR
Davis Ryman
Executive officer
WG
William Greene
Director
MZ
Micah Zajic
Executive officer
LE
Lars Ekman
Director
JG
Justin Gover
Director
AH
Allison Hulme
Chief Executive Officer & Director
Alumis Inc. · Form D, Mar 11, 2024
ZY
Zhengbin Yao
Director
SS
Sapna Srivastava
Director
MB
Martin Babler
CEO and director
AC
Alan Colowick
Director
JB
Julian Baker
Director
JT
James Tananbaum
Director
SA
Srinivas Akkaraju
Director
Attralus, Inc. · Form D, Feb 9, 2024
MT
Mark Timney
Chief Executive Officer and Director
MK
Mehdi Khodadad
Executive officer
CG
Corey Goodman
Director
GF
Glen Firestone
Executive officer
RK
Rahul Kakkar
Director
GB
Gregory Bell
Executive officer
SG
Spencer Guthrie
Executive officer
JT
James Testa
Executive officer
JB
Jake Bauer
Director
NR
Nancy Miller-Rich
Director
AD
Alex Denner
Director